These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8752159)

  • 41. Maximizing expression of eukaryotic cytochrome P450s in Escherichia coli.
    Barnes HJ
    Methods Enzymol; 1996; 272():3-14. PubMed ID: 8791757
    [No Abstract]   [Full Text] [Related]  

  • 42. Purification of functional recombinant P450s from bacteria.
    Guengerich FP; Martin MV; Guo Z; Chun YJ
    Methods Enzymol; 1996; 272():35-44. PubMed ID: 8791760
    [No Abstract]   [Full Text] [Related]  

  • 43. Polymorphic forms of the Ah receptor and induction of the CYP1A1 gene.
    Fujii-Kuriyama Y; Ema M; Mimura J; Matsushita N; Sogawa K
    Pharmacogenetics; 1995; 5 Spec No():S149-53. PubMed ID: 7581486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sheep lung cytochrome P4501A1 (CYP1A1): cDNA cloning and transcriptional regulation by oxygen tension.
    Hazinski TA; Noisin E; Hamon I; DeMatteo A
    J Clin Invest; 1995 Oct; 96(4):2083-9. PubMed ID: 7560103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epoxidation of benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 in reconstituted membranes. Effects of charge and nonbilayer phase propensity of the membrane.
    Kisselev P; Schwarz D; Platt KL; Schunck WH; Roots I
    Eur J Biochem; 2002 Apr; 269(7):1799-805. PubMed ID: 11952781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Azidowarfarin photoaffinity probes of purified rat liver cytochrome P4501A1.
    Obach RS; Spink DC; Chen N; Kaminsky LS
    Arch Biochem Biophys; 1992 Apr; 294(1):215-22. PubMed ID: 1550348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetically engineered bacterial cells and applications.
    Waterman MR; Jenkins CM; Pikuleva I
    Toxicol Lett; 1995 Dec; 82-83():807-13. PubMed ID: 8597146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility.
    Persson I; Johansson I; Ingelman-Sundberg M
    Biochem Biophys Res Commun; 1997 Feb; 231(1):227-30. PubMed ID: 9070254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis.
    Zhu W; Liu H; Wang X; Lu J; Zhang H; Wang S; Yang W
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30765615
    [No Abstract]   [Full Text] [Related]  

  • 50. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction.
    Liu D; Qin S; Ray B; Kalari KR; Wang L; Weinshilboum RM
    Drug Metab Dispos; 2018 Sep; 46(9):1372-1381. PubMed ID: 29980579
    [No Abstract]   [Full Text] [Related]  

  • 51. Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.
    Rendic SP; Guengerich FP
    Curr Drug Metab; 2018; 19(1):3-46. PubMed ID: 29219051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CYP1A1 I462V polymorphism is associated with reduced genotoxicity in yeast despite positive association with increased cancer risk.
    Freedland J; Cera C; Fasullo M
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Mar; 815():35-43. PubMed ID: 28283091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.
    Chang I; Fukuhara S; Wong DK; Gill A; Mitsui Y; Majid S; Saini S; Yamamura S; Chiyomaru T; Hirata H; Ueno K; Arora S; Shahryari V; Deng G; Tabatabai ZL; Greene KL; Shin DM; Enokida H; Shiina H; Nonomura N; Dahiya R; Tanaka Y
    Tumour Biol; 2014 Oct; 35(10):10223-30. PubMed ID: 25027399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
    Roszak A; Lianeri M; Sowińska A; Jagodziński PP
    Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of heme precursors on CYP1A2 and POR expression in the baculovirus/Spodoptera frugiperda system.
    Lu H; Ma J; Liu N; Wang S
    J Biomed Res; 2010 May; 24(3):242-9. PubMed ID: 23554636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CYP1A1 genotypes and haplotypes and risk of oral cancer: A case-control study in South Indians.
    Balaji L; Singh KB; Bhaskar LV
    Genet Mol Biol; 2012 Apr; 35(2):407-12. PubMed ID: 22888287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking.
    Han F; Wang X; Wang X; Luo Y; Li W
    Mol Biol Rep; 2012 Aug; 39(8):8335-44. PubMed ID: 22707145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.
    Klein K; Winter S; Turpeinen M; Schwab M; Zanger UM
    Front Pharmacol; 2010; 1():129. PubMed ID: 21918647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda.
    Wickliffe JK; Abdel-Rahman SZ; Lee C; Kormos-Hallberg C; Sood G; Rondelli CM; Grady JJ; Desnick RJ; Anderson KE
    Mol Med; 2011; 17(3-4):241-7. PubMed ID: 20957336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
    Androutsopoulos VP; Tsatsakis AM; Spandidos DA
    BMC Cancer; 2009 Jun; 9():187. PubMed ID: 19531241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.